SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jonathan Schonsheck who wrote (4085)1/15/1999 11:47:00 AM
From: Hank   of 4342
 
Jonathan,

Most drug companies require substantial experimental data before they will put any money behind a potential drug. Once they are convinced that it is worth the effort, they take on the responsibility of developing the drug for subsequent development. The question is, does PRLN have enough data to convince them at this point? Hopefully, the mice will do their job and give them all the data they will need. I would prefer to wait until they have successfully either 1) documented substantial and reoccurring profits from BioFit and/or 2) successfully nailed down a license agreement with a big drug company before I buy back in. Sure, I would be buying at a higher price at that point but at least I'd more confidence in PRLN's future. Discretion is the better part of valor where companies like PRLN are concerned. We should have all learned that after what happened the last time around. At this point, they are still speculative IMHO.

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News